Prenatal screening and diagnostic services help expectant mothers and their families identify fetal health risks early and develop appropriate pregnancy management plans. The main screening and diagnostic procedures include:
● Down Syndrome Screening
○ Non-invasive Prenatal Testing (NIPT): Available from 10 weeks onwards (such as SafeT21 and NIFTY Pro), this blood test analyzes fetal chromosomal abnormalities with an accuracy of up to 99%.
○ Nuchal Translucency Ultrasound (NT Scan): Suitable for pregnant women between 11-13 weeks, this ultrasound measures the thickness of the fetal neck’s translucent layer and, combined with blood tests, assesses the risk of Down syndrome.
● Structural Ultrasound
○ Timing: Between 18 and 22 weeks of pregnancy.
○ Scope: A detailed examination of the fetal major organs and development, including the heart, brain, spine, limbs, and internal organs. This scan can detect approximately 80% of structural abnormalities, such as congenital heart defects and spina bifida.
● Preeclampsia Screening
○ Screening period: 11–13 weeks.
○ Screening details: Combines blood pressure measurement, blood biochemical markers, and uterine artery Doppler assessment to evaluate the risk of preeclampsia and develop a personalized monitoring plan at an early stage.
● Amniocentesis
○ Suitable candidates: Those showing high risk from NIPT or nuchal translucency screening.
○ Screening period: 15–20 weeks.
○ Screening details : Extraction of fetal cells from amniotic fluid for chromosomal testing with over 99% accuracy, capable of diagnosing Down syndrome and other chromosomal abnormalities.
